Main Article Content Eric Simpson Oregon Health & Science University, Portland, OR, USA Robert Bissonnette Innovaderm Research, Montreal, QC, Canada Michael Kuligowski Incyte Corporation, Wilmington, DE, USA May Venturanza Incyte Corporation, Wilmington, DE, USA Kang Sun Incyte Corporation, Wilmington, DE, USA Jonathan Silverberg George Washington University School of Medicine Keywords ruxolitinib cream, atopic dermatitis, head and/or neck Abstract N/A References 1. Langan SM, et al. Lancet.
